Compare TELA & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TELA | COSM |
|---|---|---|
| Founded | 2012 | 2009 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.4M | 33.8M |
| IPO Year | 2019 | 2009 |
| Metric | TELA | COSM |
|---|---|---|
| Price | $0.69 | $2.92 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | $2.00 | ★ $59.00 |
| AVG Volume (30 Days) | 122.1K | ★ 1.8M |
| Earning Date | 11-10-2026 | 12-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 37.59 | ★ 46.15 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $80,275,000.00 | $65,271,815.00 |
| Revenue This Year | N/A | $30.85 |
| Revenue Next Year | $8.83 | $51.74 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 15.84 | ★ 19.93 |
| 52 Week Low | $0.50 | $0.16 |
| 52 Week High | $1.50 | $4.35 |
| Indicator | TELA | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 35.19 | 77.41 |
| Support Level | $0.60 | $0.24 |
| Resistance Level | $0.98 | $4.35 |
| Average True Range (ATR) | 0.12 | 0.35 |
| MACD | -0.01 | 0.28 |
| Stochastic Oscillator | 9.14 | 66.49 |
TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.